Blau Farmaceutica SA 

R$9.68
21
+R$0.18+1.89% Friday 20:05

Statistics

Day High
9.4
Day Low
9.4
52W High
14.5
52W Low
8.28
Volume
431,800
Avg. Volume
-
Mkt Cap
2.26B
P/E Ratio
16.35
Dividend Yield
4.62%
Dividend
0.45

Upcoming

Dividends

4.62%Dividend Yield
Jul 26
R$0.08
Apr 26
R$0.08
Dec 25
R$0.43
Dec 25
R$0.09
Oct 25
R$0.07
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
7.28%
1Y Growth
316.97%

Earnings

10NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
0.15
0.27
0.39
0.51
Expected EPS
0.34352755895430004
Actual EPS
N/A

Financials

12.38%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
1.75BRevenue
217.21MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BLAU3.SA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap162.16B
Pfizer is a global pharmaceutical company that competes in various therapeutic areas similar to Blau Farmaceutica, making it a direct competitor.
Merck
MRK
Mkt Cap370.89B
Merck operates globally in the pharmaceutical sector, offering products that directly compete with Blau Farmaceutica's portfolio.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson has a broad range of healthcare products that overlap with Blau Farmaceutica's offerings, especially in pharmaceuticals.
Abbvie
ABBV
Mkt Cap453.19B
AbbVie competes in the pharmaceutical industry with a focus on biopharmaceuticals, directly challenging Blau Farmaceutica's market.
Novartis
NVS
Mkt Cap304.1B
Novartis is a global healthcare company with a strong presence in the pharmaceutical sector, competing in several therapeutic areas covered by Blau Farmaceutica.
GSK
GSK
Mkt Cap99.96B
GlaxoSmithKline operates in the pharmaceutical and healthcare industry, offering products that compete with Blau Farmaceutica's range.
Sanofi
SNY
Mkt Cap106.01B
Sanofi is a global pharmaceutical company with a diverse portfolio that competes across many of the same areas as Blau Farmaceutica.
Bristol-Myers Squibb
BMY
Mkt Cap136.49B
Bristol Myers Squibb is a global biopharmaceutical company whose products and research areas often overlap with those of Blau Farmaceutica.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a major player in the pharmaceutical and diagnostics world, competing with Blau Farmaceutica in several key areas.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Blau Farmaceutica in developing and commercializing prescription medicines.

About

Blau Farmacêutica S.A. operates as a pharmaceutical enterprise, supplying private label medications across Brazil, Argentina, Colombia, the United States, Ecuador, Peru, and Uruguay. Its extensive product portfolio encompasses a broad spectrum of therapeutic areas, including immunology, hematology, oncology, nephrology, specialized treatments, and antibiotics. The company's offerings also extend to biological drugs, oral and injectable therapies for cancer, specialized treatments for infectious diseases, and a range of prescription and over-the-counter products like dermo-medicines and contraceptives, catering to both retail and non-retail markets. Additionally, Blau provides pharmaceuticals derived from blood, biological and biotechnological agents, and antiretroviral drugs. Its client base includes hospitals, private medical clinics, chemotherapy and hemodialysis centers, and public health institutions. Established in 1987, the firm's corporate headquarters are situated in Cotia, Brazil.
Show more...
CEO
Marcelo Rodolfo Hahn
Employees
1900
Country
Brazil
ISIN
BRBLAUACNOR8

Listings

0 Comments

Share your thoughts

FAQ

What is Blau Farmaceutica SA stock price today?
The current price of BLAU3.SA is R$9.68 BRL — it has increased by +1.89% in the past 24 hours. Watch Blau Farmaceutica SA stock price performance more closely on the chart.
What is Blau Farmaceutica SA stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Sao Paolo Exchange exchange Blau Farmaceutica SA stocks are traded under the ticker BLAU3.SA.
Is Blau Farmaceutica SA stock price growing?
BLAU3.SA stock has risen by +4.31% compared to the previous week, the month change is a +10.88% rise, over the last year Blau Farmaceutica SA has showed a -8.88% decrease.
What is Blau Farmaceutica SA market cap?
Today Blau Farmaceutica SA has the market capitalization of 2.26B
When is the next Blau Farmaceutica SA earnings date?
Blau Farmaceutica SA is going to release the next earnings report on November 10, 2026.
What were Blau Farmaceutica SA earnings last quarter?
BLAU3.SA earnings for the last quarter are 0.24 BRL per share, whereas the estimation was 0.32 BRL resulting in a -26.14% surprise. The estimated earnings for the next quarter are N/A BRL per share.
What is Blau Farmaceutica SA revenue for the last year?
Blau Farmaceutica SA revenue for the last year amounts to 1.75B BRL.
What is Blau Farmaceutica SA net income for the last year?
BLAU3.SA net income for the last year is 217.21M BRL.
Does Blau Farmaceutica SA pay dividends?
Yes, BLAU3.SA dividends are paid quarterly. The last dividend per share was 0.08 BRL. As of today, Dividend Yield (FWD)% is 4.62%.
How many employees does Blau Farmaceutica SA have?
As of September 07, 2026, the company has 1,900 employees.
In which sector is Blau Farmaceutica SA located?
Blau Farmaceutica SA operates in the Health & Wellness sector.
When did Blau Farmaceutica SA complete a stock split?
The last stock split for Blau Farmaceutica SA was on January 06, 2026 with a ratio of 13:10.
Where is Blau Farmaceutica SA headquartered?
Blau Farmaceutica SA is headquartered in Cotia, Brazil.